Specialty drug manufacturing companies focus on creating specific therapeutic products tailored to treat complex medical conditions. They play a crucial role in addressing unmet healthcare needs, particularly in areas such as oncology, rare diseases, and advanced biopharmaceuticals. Operating mainly at the intersection of research and production, these companies contribute significantly to both innovation and international healthcare. As the industry evolves, the demand for specialized medications continues to rise, driven by increased investment in biotechnology and personalized medicine, creating clearer pathways to safer and more effective treatments.

This list showcases 26 specialty drug manufacturing companies, varying in size from thousands to hundreds of employees. These firms are headquartered across multiple countries, including India, Belgium, and Brazil, with foundations dating back to the early 20th century. Their specializations range from oncology drugs to advanced biologics, reflecting a commitment to complex medical challenges. Each company is recognized for meeting demanding quality standards while striving to enhance patient health across global markets.

Continue reading to explore the top specialty drug manufacturing companies.

Top 26 Specialty Drug Manufacturing Companies

1. Intas Pharmaceuticals

• Website: intaspharma.com
• Ownership type: Private Equity
• Headquarters: Ahmedabad, Gujarat, India
• Employee distribution: India 99%, Other 1%
• Latest funding: October 2022
• Founded year: 2000
• Headcount: 10001+
• LinkedIn: intas-biopharmaceuticals

Intas Pharmaceuticals Limited, founded in 2000 and based in Ahmedabad, Gujarat, India, is a pharmaceutical company that specializes in the development, manufacturing, and marketing of generic therapeutic drugs. With over 17,000 employees, Intas operates primarily in India, but its reach extends to more than 85 countries worldwide. The company is dedicated to addressing unmet medical needs through innovative products and a strong commitment to quality. Intas has a comprehensive product portfolio that includes generics, oncology products, and biologics, with a significant focus on R&D. The company has invested around 6-7% of its turnover annually into research and development, employing over 550 scientists and researchers across 17 advanced facilities. Intas is recognized for its high-quality standards, with manufacturing facilities approved by major global regulatory agencies, including the USFDA and EMA. This commitment to quality and innovation positions Intas as a notable player in the pharmaceutical industry, particularly in the specialty drug segment.

2. Chiesi Group

• Website: chiesi.com
• Ownership type: Private
• Headquarters: Parma, Emilia-Romagna, Italy
• Employee distribution: Italy 64%, Pakistan 3%, United Kingdom (UK) 3%, Other 30%
• Founded year: 1935
• Headcount: 5001-10000
• LinkedIn: chiesi-group

Chiesi Group, officially known as Chiesi Farmaceutici S.p.A., is an international biopharmaceutical company headquartered in Parma, Italy. Founded in 1935, the company has over 85 years of experience in the pharmaceutical industry. Chiesi specializes in the research, development, and commercialization of innovative therapeutic solutions, particularly targeting respiratory health, rare diseases, and specialty care. With a workforce of approximately 5,751 employees, Chiesi operates in more than 100 countries and has established a direct presence in 31 of them. The company emphasizes a patient-centered approach, aiming to enhance the quality of life for individuals through effective treatments. Chiesi's commitment to sustainability is evident in its operations, as it has adopted the B Corp certification, reflecting its dedication to social and environmental responsibility. The company has production facilities in Parma, Italy, Blois, France, and Santana de Parnaíba, Brazil, and maintains a robust pipeline of clinical trials and research initiatives.

3. Eisai Co., Ltd.

• Website: eisai.com
• Ownership type: Private
• Headquarters: Bunkyo City, Tokyo, Japan
• Employee distribution: Japan 54%, Vietnam 8%, United States (USA) 6%, Other 32%
• Founded year: 1941
• Headcount: 1001-5000
• LinkedIn: %e3%82%a8%e3%83%bc%e3%82%b6%e3%82%a4%ef%bc%88%e6%a0%aa%ef%bc%89

Eisai Co., Ltd., founded in 1941 and based in Bunkyo City, Tokyo, Japan, is a pharmaceutical company dedicated to drug discovery and development. The company primarily focuses on creating innovative treatments for various health conditions, with a strong emphasis on oncology and neurology. Eisai aims to enhance patient outcomes and access to medicines through its extensive research and development efforts. With a workforce of approximately 622 employees, the company operates not only in Japan but also has a presence in countries like Vietnam, the United States, Taiwan, and Thailand. Eisai is actively involved in clinical trials and has a significant pipeline of research initiatives, showcasing its commitment to advancing healthcare solutions. Their approach includes collaboration with healthcare providers and organizations to ensure that their innovative therapies reach those in need.

4. Blau Farmacêutica

• Website: blau.com.br
• Ownership type: Private
• Headquarters: Cotia, Sao Paulo, Brazil
• Founded year: 1987
• Headcount: 1001-5000
• LinkedIn: blausiegel

Blau Farmacêutica, founded in 1987 and based in Cotia, São Paulo, Brazil, is a private pharmaceutical company that specializes in high-complexity medications and biotechnology solutions. With a workforce of approximately 959 employees, the company operates multiple manufacturing facilities equipped with advanced technology. Blau Farmacêutica serves hospitals and healthcare providers across Latin America and the United States, focusing on innovative therapies that aim to improve patient care and reduce treatment side effects. Their product portfolio includes medications for critical areas such as oncology, hematology, and immunology, addressing the needs of patients with complex health conditions. The company is also involved in research and development, emphasizing their commitment to advancing healthcare solutions. Blau Farmacêutica is publicly traded on the Brazilian stock exchange under the ticker "BLAU3," reflecting its established presence in the pharmaceutical industry.

5. PROBIOMED S.A. de C.V.

• Website: probiomed.com.mx
• Ownership type: Corporate
• Headquarters: Mexico
• Employee distribution: Mexico 99%
• Latest funding: May 2022
• Founded year: 1970
• Headcount: 501-1000
• LinkedIn: probiomedmx

PROBIOMED S.A. de C.V. is a Mexican biopharmaceutical company established in 1970. The company is dedicated to the research, development, manufacturing, and commercialization of pharmaceutical products that cater to human health. With a workforce of approximately 657 employees, PROBIOMED focuses on creating high-tech biopharmaceuticals aimed at treating serious diseases. Their product offerings include a wide array of therapies for conditions such as cancer, chronic kidney disease, rheumatoid arthritis, multiple sclerosis, and diabetes. The company also specializes in producing chemical synthesis generics and biocomparables, including cytokines, monoclonal antibodies, fusion proteins, and recombinant vaccines. PROBIOMED's commitment to enhancing patient access to effective treatments underscores its role in the biopharmaceutical industry, making it a significant player in the specialty drug manufacturing sector.

6. Kedrion Biopharma

• Website: kedrion.com
• Ownership type: Private Equity
• Headquarters: Fort Lee, New Jersey, United States (USA)
• Employee distribution: Italy 49%, United States (USA) 27%, United Kingdom (UK) 14%, Other 11%
• Latest funding: September 2022
• Founded year: 2001
• Headcount: 1001-5000
• LinkedIn: kedrion-biopharma

Kedrion Biopharma is a biopharmaceutical company founded in 2001, headquartered in Fort Lee, New Jersey. The company specializes in the collection and fractionation of blood plasma to produce and distribute plasma-derived therapies for rare and debilitating diseases. Their product portfolio includes treatments for conditions such as coagulation disorders and immunodeficiencies. Kedrion operates globally, with production facilities in multiple countries and a network of plasma collection centers in the United States and the Czech Republic. The company has expanded its capabilities through strategic acquisitions, including the purchase of Bio Products Laboratory in 2022, enhancing its position in the market. Kedrion is dedicated to maintaining high industry standards and aims to support national health systems in achieving self-sufficiency in plasma-derived products. Their commitment to quality, safety, and social responsibility is evident in their operations and community engagement efforts.

7. Par Pharmaceutical

• Website: parpharm.com
• Ownership type: Corporate
• Headquarters: Chestnut Ridge, New York, United States (USA)
• Employee distribution: India 57%, United States (USA) 42%
• Latest funding: $8.1B, May 2015
• Founded year: 1978
• Headcount: 501-1000
• LinkedIn: par-pharmaceutical

Par Pharmaceutical, a subsidiary of Endo International, is based in Chestnut Ridge, New York. Founded in 1978, the company has established itself as a key player in the pharmaceutical industry, focusing on specialty medicines, sterile injectables, and generic products. Par Pharmaceutical is dedicated to improving health outcomes for patients by providing innovative therapies across various medical fields, including urology, orthopedics, and pediatric endocrinology. With a workforce of approximately 1,415 employees, the company operates a global manufacturing network that spans over one million square feet, ensuring high-quality production standards. Their commitment to research and development is evident in their extensive pipeline, which includes numerous products aimed at addressing specific patient needs. Par Pharmaceutical's strategic partnerships with healthcare providers and hospitals further enhance their ability to deliver effective solutions to the market.

8. Laboratorios Bagó

• Website: bago.com.ar
• Ownership type: Private
• Headquarters: General Pacheco, Buenos Aires, Argentina
• Employee distribution: Argentina 70%, Brazil 6%, Ecuador 4%, Other 19%
• Founded year: 1934
• Headcount: 5001-10000
• LinkedIn: laboratorios_bago

Laboratorios Bagó is a private pharmaceutical company based in General Pacheco, Buenos Aires, Argentina. Established in 1934, it specializes in the development and manufacturing of prescription and over-the-counter medications. The company is dedicated to research and development, focusing on creating innovative healthcare solutions that serve healthcare professionals, hospitals, and patients. With a workforce of approximately 5,000 to 10,000 employees, Laboratorios Bagó operates in multiple countries, including Argentina, Brazil, Ecuador, Chile, and Peru, among others. Their commitment to quality is reflected in their adherence to stringent international standards and their extensive portfolio of products, which are recognized for their therapeutic effectiveness. The company has made significant strides in the pharmaceutical industry, including the development of original molecules and a strong emphasis on pharmacovigilance to ensure patient safety. Laboratorios Bagó continues to strive for excellence in healthcare, aiming to improve health outcomes across the regions they serve.

9. Amoun Pharmaceutical Company

• Website: amoun.com
• Ownership type: Corporate
• Headquarters: Al Waili Al Kabir Sharq, Cairo Governorate, Egypt
• Employee distribution: Egypt 97%, Other 3%
• Latest funding: $740.0M, March 2021
• Founded year: 1998
• Headcount: 1001-5000
• LinkedIn: amoun-pharmaceutical-industries-company

Amoun Pharmaceutical Company S.A.E. is an Egyptian joint-stock company established in 1998. Based in El Obour City, the company operates with international standards and is recognized for its commitment to improving healthcare outcomes. Amoun specializes in the entire pharmaceutical value chain, which includes the development, manufacturing, marketing, and distribution of high-quality pharmaceutical products. The company has a significant presence in the Egyptian market, with a reported sales figure of 5.7 billion Egyptian Pounds in 2023, reflecting a compounded annual growth rate of 18% over the past five years. Amoun's manufacturing facility is one of the largest and most advanced in Africa and the Middle East, employing state-of-the-art technology to ensure product quality and safety. The company exports to over 29 countries, showcasing its commitment to expanding access to essential medications. Amoun is also affiliated with Abu Dhabi Developmental Holding Company (ADQ), which enhances its resources and expertise in the healthcare sector.

10. Esteve

• Website: esteve.com
• Ownership type: Corporate
• Headquarters: Barcelona, Catalonia, Spain
• Employee distribution: Spain 86%, Mexico 6%, France 3%, Other 6%
• Latest funding: June 2023
• Founded year: 1929
• Headcount: 1001-5000
• LinkedIn: esteve

Esteve, founded in 1929 and headquartered in Barcelona, Spain, is a pharmaceutical company dedicated to developing and manufacturing innovative medications aimed at addressing serious diseases. With a workforce of approximately 1,937 employees, Esteve operates primarily in Spain, with additional presence in Mexico, France, and other countries. The company specializes in therapeutic areas such as oncology and neurology, and it also offers contract manufacturing and research services to healthcare providers and pharmaceutical companies. Esteve has made significant strides in expanding its portfolio, particularly with the recent acquisition of HRA Pharma Rare Diseases, which enhances its offerings in the treatment of rare and severe diseases. Esteve's commitment to improving patient outcomes is evident in its ongoing investment in research and development, as well as its plans to construct a new manufacturing plant to increase production capacity. The company has reported a net revenue of €710 million, reflecting its growth and relevance in the pharmaceutical industry.

11. Sanofi Belgium

• Website: sanofi.be
• Ownership type: Private
• Headquarters: Machelen, Flanders, Belgium
• Employee distribution: Belgium 99%
• Founded year: 2004
• Headcount: 501-1000
• LinkedIn: sanofi-belgium

Sanofi Belgium, established in 2004 and located in Machelen, Flanders, is a private pharmaceutical company that plays a crucial role in the healthcare landscape. With approximately 1,600 employees across four sites in Belgium, Sanofi Belgium is involved in the entire pharmaceutical process, from research and development to the commercialization and distribution of medications. The company is particularly focused on innovative therapies for chronic and rare diseases, demonstrating a strong commitment to improving health outcomes. Their Geel site is notable for producing therapeutic proteins through cell culture, while the Ghent site is dedicated to developing NANOBODY® technology, a novel class of therapeutic proteins. Sanofi Belgium's investment in production capabilities, including a recent €120 million investment to enhance biopharmaceutical production, underscores their ongoing commitment to advancing healthcare solutions. The company also engages in various social initiatives, reflecting their dedication to corporate responsibility.

12. NPS Pharma

• Website: shire.com
• Ownership type: Corporate
• Headquarters: Bedminster, New Jersey, United States (USA)
• Employee distribution: United States (USA) 51%, Algeria 12%, Ireland 12%, Other 25%
• Latest funding: $86.4B, April 2018
• Founded year: 1986
• Headcount: 201-500
• LinkedIn: nps-pharmaceuticals

NPS Pharma, originally founded in 1986, is a pharmaceutical company based in Bedminster, New Jersey. It specializes in the research, development, and manufacturing of innovative medicines, particularly in the areas of rare diseases and gastrointestinal disorders. The company has a strong focus on creating treatments for conditions that often lack effective options, thereby addressing significant unmet medical needs. NPS Pharma became part of Takeda Pharmaceutical Company Limited, which has expanded its capabilities and reach in the pharmaceutical industry. Takeda is known for its commitment to transforming lives through its extensive portfolio of pharmaceutical products, including those developed by NPS Pharma. The company has received substantial funding, with the last reported amount being over $86 billion in April 2018, indicating strong investor confidence in its potential and growth trajectory.

13. Mundipharma

• Website: mundipharma.com
• Ownership type: Corporate
• Headquarters: Cambridge, England, United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 27%, United Arab Emirates 6%, Brazil 5%, Other 63%
• Latest funding: June 2023
• Founded year: 1952
• Headcount: 1001-5000
• LinkedIn: mundipharma

Mundipharma International Limited, founded in 1952 and headquartered in Cambridge, England, is a multinational pharmaceutical company dedicated to research-based drug development. With a workforce of over 2,100 employees, the company operates globally, providing innovative treatments primarily in pain management and oncology. Mundipharma's product offerings include a range of medications for various health conditions, such as opioids for pain relief and biosimilars for cost-effective treatment options. The company has established partnerships to enhance patient care and has a track record of successful marketing authorizations across multiple countries. Recently, Mundipharma sold its Consumer Health business to focus more on its prescription portfolio, reinforcing its commitment to specialty care and addressing unmet medical needs in challenging health conditions.

14. Acceleron Pharma

• Website: acceleronpharma.com
• Ownership type: Corporate
• Headquarters: Cambridge, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 94%, Canada 6%
• Latest funding: $11.5B, September 2021
• Founded year: 2003
• Headcount: 201-500
• LinkedIn: acceleron-pharma

Acceleron Pharma, founded in 2003 and based in Cambridge, Massachusetts, is a biotechnology company dedicated to developing innovative therapies for serious diseases. The company primarily focuses on hematology and pulmonary medicine, aiming to address significant unmet medical needs in these areas. Acceleron has made strides in advancing its pipeline of drug candidates, particularly in the treatment of conditions like pulmonary arterial hypertension and other rare diseases. The company has received substantial funding, with a reported last funding amount of $115 million in September 2021, which underscores investor confidence in its potential to deliver impactful therapies. Acceleron's commitment to research and development positions it as a relevant player in the specialty drug manufacturing sector.

15. MSD Sharp & Dohme GmbH

• Website: msd.de
• Ownership type: Private
• Headquarters: Amt Neuhaus, Lower Saxony, Germany
• Founded year: 2001
• Headcount: 1001-5000
• LinkedIn: msd-sharp-%26-dohme-gmbh

MSD Sharp & Dohme GmbH, a subsidiary of Merck & Co., Inc., is a pharmaceutical company based in Amt Neuhaus, Lower Saxony, Germany. Founded in 2001, the company specializes in the research, development, and manufacturing of a wide range of medications and vaccines. MSD is particularly focused on addressing health challenges in oncology and infectious diseases, striving to provide innovative solutions that enhance patient care. The company serves healthcare providers, hospitals, and patients, emphasizing accessibility and the improvement of global health outcomes. MSD's commitment to clinical research and its extensive pipeline of products reflect its active involvement in the pharmaceutical industry, making it a notable entity in the specialty drug manufacturing sector.

16. MedImmune

• Website: medimmune.com
• Ownership type: Venture Capital
• Headquarters: Gaithersburg, Maryland, United States (USA)
• Employee distribution: United States (USA) 78%, United Kingdom (UK) 18%, Other 4%
• Latest funding: $15.6B, April 2007
• Founded year: 1987
• Headcount: 1001-5000
• LinkedIn: medimmune

MedImmune, founded in 1987 and based in Gaithersburg, Maryland, is a biopharmaceutical company that operates as a subsidiary of AstraZeneca. It specializes in the research and development of innovative medicines, particularly targeting oncology, respiratory diseases, and rare diseases. MedImmune is committed to improving health outcomes through its extensive pipeline of products. The company has a significant presence in the United States, with a workforce that is primarily based there. MedImmune's focus on precision medicine and transformative science positions it as a key player in the biopharmaceutical sector, contributing to advancements in specialty drug development.

17. Pharmasyntez Group of Companies

• Website: pharmasyntez.com
• Ownership type: Private
• Headquarters: Russia
• Employee distribution: Russia 96%, China 4%
• Founded year: 1997
• Headcount: 1001-5000
• LinkedIn: jsc-pharmasyntez

Pharmasyntez Group of Companies, established in 1997, is a private pharmaceutical entity based in Russia. The company is dedicated to the development and production of medications that address significant health challenges, including tuberculosis, HIV, oncology, diabetes, hepatitis, and COVID-19. With a workforce of over 4,000 skilled professionals, Pharmasyntez operates five manufacturing facilities located in various cities across Russia, including Irkutsk, Ussuriysk, Tyumen, Saint Petersburg, and Bratsk. The company emphasizes the importance of high-quality pharmaceuticals, ensuring that healthcare providers and patients have access to essential medications. Pharmasyntez also actively seeks collaboration with both domestic and international pharmaceutical companies, highlighting its commitment to innovation and partnership in the healthcare sector.

18. Pinnacle Life Science Pvt. Ltd (Subsidiary of Aarti Drugs)

• Website: pinnaclelifescience.com
• Ownership type: Private
• Headquarters: Mumbai, Maharashtra, India
• Employee distribution: India 96%, Chile 2%, Other 2%
• Founded year: 2014
• Headcount: 1001-5000
• LinkedIn: pinnacle-lifescience-private-limited

Pinnacle Life Science Pvt. Ltd, a subsidiary of Aarti Drugs, was established in 2014 and is based in Mumbai, Maharashtra, India. The company focuses on the formulation and export of innovative pharmaceutical solutions, particularly in oncology, cardiovascular health, anti-infectives, and diabetes management. With a workforce of approximately 295 employees, Pinnacle operates state-of-the-art manufacturing facilities in Baddi, Himachal Pradesh, which have received US FDA and multiple GMP approvals. This enables them to produce billions of tablets and capsules annually, catering to a global network of healthcare providers and pharmaceutical companies. Their commitment to quality and safety is evident in their rigorous adherence to international regulatory standards. Pinnacle Life Science is dedicated to advancing healthcare through continuous investment in research and development, ensuring they meet the evolving needs of patients worldwide.

19. Macleods Pharmaceuticals LTD.

• Website: macleodspharma.com
• Ownership type: Private
• Headquarters: Mumbai, Maharashtra, India
• Employee distribution: India 98%, Other 2%
• Founded year: 1989
• Headcount: 10001+
• LinkedIn: macleods-pharmaceuticals-ltd.

Macleods Pharmaceuticals LTD., founded in 1989 and based in Mumbai, Maharashtra, India, is a private pharmaceutical company that develops, manufactures, and markets a broad spectrum of pharmaceutical products. With over 10,000 employees, the company serves healthcare providers, hospitals, and pharmacies, focusing on various therapeutic areas including anti-infectives, cardiovascular, and anti-diabetic medications. Macleods operates multiple manufacturing units that adhere to stringent quality standards and regulatory requirements, ensuring the production of high-quality medicines. The company also invests in research and development, with facilities dedicated to the development of active pharmaceutical ingredients (APIs) and formulations. Their global presence spans several countries, including the USA, UK, and South Africa, allowing them to distribute their products widely. Macleods Pharmaceuticals is committed to making quality medicines accessible to patients around the world.

20. Kyowa Kirin International plc.

• Website: kyowakirininternational.com
• Ownership type: Private
• Headquarters: Galashiels, Scotland, United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 42%, Spain 14%, France 9%, Other 35%
• Founded year: 1995
• Headcount: 501-1000
• LinkedIn: kyowa-kirin-international-plc.

Kyowa Kirin International plc, based in Galashiels, Scotland, is a pharmaceutical company founded in 1995. The company is dedicated to the development of innovative medicines and therapies, with a strong emphasis on addressing high unmet medical needs. Their portfolio includes treatments for various conditions, particularly rare diseases, showcasing their commitment to improving patient outcomes. With a workforce of approximately 696 employees, Kyowa Kirin operates in multiple countries, including the UK, Spain, France, Germany, and the UAE. The company has a rich heritage in drug discovery and biotechnology, having invested in these areas for over 70 years. Their ongoing efforts include engineering next-generation antibodies and cell and gene therapies, reflecting their focus on cutting-edge medical solutions. Kyowa Kirin's customer base primarily consists of healthcare professionals and organizations seeking advanced pharmaceutical options.

21. Pfizer 21

• Website: pfizer.dk
• Ownership type: Private
• Headquarters: Manchester Township, New Jersey, United States (USA)
• Employee distribution: India 74%, Saudi Arabia 26%
• Founded year: 1998
• Headcount: 5001-10000
• LinkedIn: pfizer-21

Pfizer 21, based in Manchester Township, New Jersey, is a private biopharmaceutical company founded in 1998. It operates as part of the larger Pfizer organization, which has been a significant player in the pharmaceutical industry since its inception in 1849. Pfizer 21 specializes in the research, development, and manufacturing of innovative medications aimed at improving health outcomes for patients worldwide. The company collaborates closely with healthcare providers and organizations to enhance patient care through a broad portfolio of prescription medications. Pfizer 21 is particularly focused on clinical research, which is essential for developing new treatments and improving existing ones. The company employs a substantial workforce, with a notable presence in India and Saudi Arabia, reflecting its global operational strategy. Pfizer 21's commitment to innovation and collaboration with healthcare professionals underscores its role in advancing medical science and patient care.

22. Adamed Pharma

• Website: adamed.com
• Ownership type: Private
• Headquarters: Warsaw, Masovian Voivodeship, Poland
• Employee distribution: Poland 92%, Spain 3%, Other 5%
• Founded year: 1986
• Headcount: 1001-5000
• LinkedIn: adamed

Adamed Pharma S.A. is a Polish pharmaceutical and biotechnology company based in Warsaw, founded in 1986. With a workforce of over 1,500 employees, the company specializes in developing and manufacturing high-quality medicinal products aimed at treating chronic diseases. Their product offerings include prescription drugs, over-the-counter medications, dietary supplements, dermocosmetics, and medical devices. Adamed Pharma is dedicated to innovation, focusing on original drug development and enhancing existing therapies. The company operates in multiple therapeutic areas and has a significant presence in Poland, with a growing international footprint. Adamed Pharma is committed to ensuring the safety and efficacy of its products, actively engaging in research and development to meet the evolving needs of patients and healthcare professionals.

23. Iclos Uruguay

• Website: iclos.com.uy
• Ownership type: Private
• Headquarters: Montevideo, Montevideo, Uruguay
• Employee distribution: Uruguay 100%
• Founded year: 2019
• Headcount: 51-200
• LinkedIn: iclos-uruguay

Iclos Uruguay is a private pharmaceutical company based in Montevideo, Uruguay, founded in 2019. The company specializes in the development and manufacturing of medications aimed at treating high complexity diseases, with a strong emphasis on oncology and immunology. Iclos is committed to improving patient quality of life through effective treatments and has established a robust research and development framework to support this mission. Their production facilities are equipped with advanced technology and adhere to Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP), ensuring high-quality standards in their products. Iclos operates a regional pharmacovigilance center to monitor the safety and efficacy of their medications post-market. The company is part of the Megalabs group, which enhances its capabilities and market reach across Latin America. Iclos Uruguay's products are available in 23 countries, reflecting their growing influence in the pharmaceutical sector.

24. Veropharm

• Website: veropharm.ru
• Ownership type: Corporate
• Headquarters: Moscow, Moscow, Russia
• Employee distribution: Russia 100%
• Latest funding: $305.0M, December 2014
• Founded year: 1997
• Headcount: 1001-5000
• LinkedIn: veropharm-oao

Veropharm, established in 1997 and headquartered in Moscow, Russia, is a pharmaceutical manufacturer focused on producing high-quality medicines and medical products. The company operates in key therapeutic areas such as oncology, infectious diseases, women's health, gastroenterology, dermatology, and neurology. With a product portfolio exceeding 200 items, Veropharm is dedicated to making effective treatments accessible to healthcare providers and patients alike. Their manufacturing facilities are equipped to meet high international standards, including GMP, and they utilize modern technologies to ensure quality and safety. Veropharm also engages in educational initiatives, collaborating with universities to foster the development of future industry professionals. This commitment to innovation and quality positions Veropharm as a significant player in the pharmaceutical sector.

25. Alexion Pharmaceuticals, Inc.

• Website: alexion.com
• Ownership type: Venture Capital
• Headquarters: Boston, Massachusetts, United States (USA)
• Employee distribution: United States (USA) 45%, Ireland 21%, Spain 8%, Other 26%
• Latest funding: $39.0B, December 2020
• Founded year: 1992
• Headcount: 1001-5000
• LinkedIn: alexion-pharmaceuticals

Alexion Pharmaceuticals, Inc., founded in 1992 and headquartered in Boston, Massachusetts, is a biopharmaceutical company dedicated to developing innovative therapies for patients suffering from rare and severe diseases. The company specializes in orphan drugs, which are designed to treat conditions that affect a small percentage of the population. Their product offerings include treatments for atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), hypophosphatasia (HPP), lysosomal acid lipase deficiency (LAL-D), neuromyelitis optica spectrum disorder (NMOSD), and paroxysmal nocturnal hemoglobinuria (PNH). Alexion's focus on rare diseases allows them to address significant unmet medical needs, providing hope and effective treatment options for patients and healthcare providers alike. The company has a global presence, with operations in multiple countries, and has received substantial funding, indicating strong investor confidence in its mission and potential for growth.

26. Hetero Healthcare Limited

• Website: heterohealthcare.com
• Ownership type: Private
• Headquarters: Hyderabad, Telangana, India
• Employee distribution: India 100%
• Founded year: 1994
• Headcount: 1001-5000
• LinkedIn: hetero-healthcare-limited

Hetero Healthcare Limited, based in Hyderabad, Telangana, India, is a private pharmaceutical company founded in 1994. With a workforce of approximately 1,690 employees, the company focuses on the development and manufacturing of generic drugs, particularly in the fields of oncology and antiretroviral (ARV) therapies. Hetero Healthcare is dedicated to providing innovative pharmaceutical solutions that enhance patient care and improve quality of life. The company has made significant strides in research and development, evidenced by their successful launch of the first generic 'COVIFOR' (Remdesivir) in India, which was crucial during the COVID-19 crisis. They also manufacture other critical medications, including Oseltamivir and various biosimilars. Hetero Healthcare's commitment to addressing pressing medical needs through their product offerings and R&D initiatives positions them as a notable entity in the pharmaceutical industry.

Specialty Drug Manufacturing Insights: Key Companies

Want to Find More Specialty Drug Manufacturing Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!